Wynnewood / San Francisco / Following Docetaxel / Washington DC / Bronx / Philadelphia / Hartford / Winston-Salem / Toronto / Buenos Aires / Orlando / Shanghai / Dublin / Barcelona / Meeting / Washington / DC / New Orleans / Atlanta / Philadelpha / Charleston / New Haven / Chicago / Mineola / /
Company
Sanofis US Services Inc. / Astex Pharmaceuticals Inc. / Celgene / Agensys Inc. / Merck / Genentech Inc. / PSMA Development Company LLC / Oncogenex Technologies Inc. / ImClone Systems Corporation / Dendreon Corporation / GTx Inc. / Sipuleucel-T / Covance Inc. / Bayer Healthcare Pharmaceuticals / /
Country
Bahamas / Bermuda / Canada / China / Italy / Argentina / Ireland / /
Currency
USD / /
Event
FDA Phase / /
Facility
American College of Pathology / Washington Cancer Institute / Memorial Sloan Kettering Cancer Center / Columbia University Medical Center / Columbia University / MD Anderson Cancer Center / University of Michigan / College of Physicians / B.A. Columbia College / Methodist University Hospital / Yale New Haven Hospital / Greenwich Hospital / Washington University / Winthrop University Hospital / Jacobi Hospital / Columbia University Cancer Center / Methodist Hospital / University of Medicine / Lankenau Medical Center / New York Presbyterian Hospital / Albert Einstein College of Medicine / Herbert Irving Cancer Center / /
IndustryTerm
Cancer Therapeutics / Therapy for Margin Positive Disease / Treatment for Prostate Cancer / Treatment of Advanced Prostate Cancer / Treatment of metastatic prostate cancer / /
MedicalCondition
Metastatic Prostate Cancer / transitional cell carcinoma / Metastatic Castrate Resistant Prostate Cancer / Bladder Cancer / Renal Cancer / Prostate Disease / Prostate Cancer / measurable disease / Cancer / Metastatic Bladder Cancer / Ulcerative colitis / Progressive CastrationResistant Metastatic Prostate Cancer / Advanced Transitional Cell Carcinoma / Advanced Disease / metastatic solid tumors / Metastatic Castration-Resistant Prostate Cancer / CastrationResistant Prostate Cancer / independent prostate cancer / resistant prostate cancer / Advanced Prostate Cancer / Disease / Metastatic Castrate-Resistant Prostate Cancer / Castrate-Resistant Prostate Cancer / Patients With Chemotherapy Naïve Metastatic Castration-Resistant Prostate Cancer / hematologic malignancies / Metastatic Transitional Cell Carcinoma / /
Yale New Haven Hospital / University of Michigan / Ann Arbor / American College of Pathology / Washington University / St. Louis / New York Presbyterian Hospital / Department of Internal Medicine / Herbert Irving Cancer Center Protocol Review Committee / Greenwich Hospital / Study of Sipuleucel-T With Concurrent Versus Sequential Administration of Enzalutamide In Men With Metastatic Castrate Resistant Prostate Cancer P.I. / IMC / Lankenau Medical Center / Global Prostate Cancer Scientific Advisory Board on Boehringer Ingelheim / Herbert Irving Cancer Center / 4th International Prostate Cancer Congress Bahamas / Columbia Comprehensive Cancer Center / Columbia University / New York / Department of Chemistry / Months Agency / Columbia College / Case Western Reserve University School of Medicine / International Congress / Columbia University Medical Center / Methodist Hospital / Yale University School of Medicine Reason for Promotion / Clinical Trials Office Advisory Board / Albert Einstein College of Medicine / American Urological Association / Current Clinical Trials Agency / European Society for Medical Oncology / American Association for Cancer Research / College of Physicians and Surgeons / University of Medicine and Dentistry of New Jersey / American Society For Clinical Oncology Annual / Grants Agency / Columbia University Cancer Center / National Institute of Health / Washington Cancer Institute / American Society for Clinical Oncology Fall Educational / 3rd International Prostate Cancer Congress Bermuda / Yale / American Society for Clinical Oncology Genitourinary Cancer / American Society for Clinical Oncology Multidisciplinary Prostate Cancer Program / Executive Committee / Winthrop University Hospital / Methodist University Hospital / Phi Delta Upsilon Honorary Chemistry Society / Congress / Pending Clinical Trials Agency / Urology Chairman Search Committee / Memorial Sloan Kettering Cancer Center / Jacobi Hospital / Forest School of Medicine / Past Clinical Trials Agency / /
Person
Joseph Paul Eder / Roy Herbst / Hari Deshpande / Charles Coltman / Herbert Irving / Karen Antman / Daniel P. Petrylak / /
Position
department chair / Professor of Clinical Medicine / Professor / Sub Investigator / Teaching Assistant / Professor of Medicine / Co-Director / Prostate Cancer Program / Attending Physician / /
Daniel P. Petrylak, M.D. CURRICULUM VITAE Date of Revision: February 7, 2014 Name: